Evaluation of the anti-tumour efficacy of Abemaciclib, a dual CDK4/6 inhibitor, both as a single agent and combined with radiotherapy in Medulloblastoma (2018)
- Grant type:
- Telethon Kids Institute
- Researchers:
-
-
- Funded by:
- Telethon Kids Institute
